CGL
SNY icon

Clarius Group LLC’s Sanofi SNY Stock Holding History

Clarius Group LLC’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,253
Closed -$350K – 468
2025
Q2 		$350K Buy
7,253
+1,610
+29% +$82.3K 0.02% 317
2025
Q1 		$313K Buy
5,643
+935
+20% +$50.6K 0.02% 346
2024
Q4 		$227K Buy
4,708
+500
+12% +$25.4K 0.02% 397
2024
Q3 		$243K Sell
4,208
-1,601
-28% -$86.4K 0.02% 374
2024
Q2 		$282K Sell
5,809
-1,366
-19% -$65.9K 0.02% 324
2024
Q1 		$349K Sell
7,175
-1,466
-17% -$71.6K 0.02% 300
2023
Q4 		$430K Sell
8,641
-742
-8% -$36.3K 0.04% 267
2023
Q3 		$503K Sell
9,383
-59
-0.6% -$3.15K 0.05% 217
2023
Q2 		$509K Buy
9,442
+57
+0.6% +$3.07K 0.04% 252
2023
Q1 		$511K Sell
9,385
-591
-6% -$28.7K 0.04% 257
2022
Q4 		$483K Buy
9,976
+2,182
+28% +$95.8K 0.04% 256
2022
Q3 		$296K Sell
7,794
-1,434
-16% -$63.9K 0.03% 350
2022
Q2 		$462K Buy
9,228
+1,009
+12% +$53.6K 0.05% 232
2022
Q1 		$412K Hold
8,219
– – 0.03% 289
2021
Q4 		$412K Buy
8,219
+2,254
+38% +$111K 0.03% 289
2021
Q3 		$288K Buy
5,965
+17
+0.3% +$864 0.03% 327
2021
Q2 		$313K Buy
5,948
+211
+4% +$11K 0.03% 304
2021
Q1 		$284K Sell
5,737
-54
-0.9% -$2.59K 0.03% 299
2020
Q4 		$281K Sell
5,791
-282
-5% -$13.9K 0.03% 272
2020
Q3 		$305K Sell
6,073
-306
-5% -$15.8K 0.04% 211
2020
Q2 		$326K Buy
6,379
+550
+9% +$26.7K 0.05% 204
2020
Q1 		$255K Buy
5,829
+25
+0.4% +$1.2K 0.05% 204
2019
Q4 		$297K Buy
5,804
+355
+7% +$16.6K 0.05% 201
2019
Q3 		$252K Buy
+5,449
New +$235K 0.05% 225
2018
Q4 		– Sell
-4,744
Closed -$212K – 139
2018
Q3 		$212K Buy
+4,744
New +$203K 0.08% 115

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Clarius Group LLC's SNY Position: Q3 2025 in Review

Clarius Group LLC sold out of Sanofi (SNY) in Q3 2025, closing a stake of 7,253 shares — an estimated $350K sold.

Clarius Group LLC first reported a position in SNY in Q3 2018 and held it in 25 quarters. The position peaked at $511K in Q1 2023. 711 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Clarius Group LLC reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Clarius Group LLC sold 7,253 Sanofi shares in Q3 2025, an estimated $350K.
  • Clarius Group LLC first reported a position in Sanofi in Q3 2018 and held it in 25 quarters.
  • Clarius Group LLC's Sanofi position peaked at $511K in Q1 2023.
  • 711 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.